Astellas Financial Statements From 2010 to 2024
| ALPMY Stock | USD 10.08 0.20 1.95% |
Check Astellas Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Astellas Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Astellas financial statements analysis is a perfect complement when working with Astellas Pharma Valuation or Volatility modules.
Astellas |
Astellas Pharma Company Current Valuation Analysis
Astellas Pharma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Astellas Pharma Current Valuation | 26.19 B |
Most of Astellas Pharma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Astellas Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Astellas Pharma has a Current Valuation of 26.19 B. This is 82.32% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The current valuation for all United States stocks is 57.52% lower than that of the firm.
Astellas Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Astellas Pharma's current stock value. Our valuation model uses many indicators to compare Astellas Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Astellas Pharma competition to find correlations between indicators driving Astellas Pharma's intrinsic value. More Info.Astellas Pharma is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.73 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Astellas Pharma is roughly 1.38 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Astellas Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Astellas Pharma's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Astellas Pharma Financial Statements
Astellas Pharma investors use historical fundamental indicators, such as Astellas Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Astellas Pharma. Please read more on our technical analysis and fundamental analysis pages.
Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals worldwide. Astellas Pharma Inc. was founded in 1923 and is headquartered in Tokyo, Japan. ASTELLAS PHARMA operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 14522 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Astellas Pink Sheet Analysis
When running Astellas Pharma's price analysis, check to measure Astellas Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astellas Pharma is operating at the current time. Most of Astellas Pharma's value examination focuses on studying past and present price action to predict the probability of Astellas Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astellas Pharma's price. Additionally, you may evaluate how the addition of Astellas Pharma to your portfolios can decrease your overall portfolio volatility.